Emergent BioSolutions
EBS
#8541
Rank
C$0.37 B
Marketcap
C$7.38
Share price
-6.36%
Change (1 day)
-46.83%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): C-$7.11

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is C-$7.23. In 2025 the company made an earnings per share (EPS) of C$1.36 an increase over its 2024 EPS that were of C-$5.20.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$7.11-622.13%
2025C$1.36-126.17%
2024C-$5.20-75.61%
2023C-$21.34232.21%
2022C-$6.42-203.46%
2021C$6.21-25.09%
2020C$8.29445.28%
2019C$1.52-15.2%
2018C$1.79-35.9%
2017C$2.8069.57%
2016C$1.65-27.67%
2015C$2.2865.62%
2014C$1.3811.63%
2013C$1.2332.31%
2012C$0.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.02-114.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-119.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.13-157.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
C-$2.58-64.29%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
C$0.76-110.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.24-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.65-108.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel